Rheumatology Therapeutics Market
Rheumatology Therapeutics Market Set to Expand from $40.45 Billion in 2023 to $51.42 Billion in 2028 - Global Long-term Forecast to 2033
10. Oktober 2024 11:23 ET | Research and Markets
Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "Rheumatology Therapeutics Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global rheumatology therapeutics market...
22157.jpg
Generic Musculoskeletal Disorders Drugs Global Market Report 2023: High Prevalence of Arthritis is Expected to Propel Growth
24. Mai 2023 10:13 ET | Research and Markets
Dublin, May 24, 2023 (GLOBE NEWSWIRE) -- The "Generic Musculoskeletal Disorders Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
Chinese Anti-Rheumatic Drug Market
China Anti-Rheumatic Drug Market Forecasts Report 2022-2027 - Growing Prevalence of Rheumatic Patients Leading to Increased Demand
20. Januar 2023 06:58 ET | Research and Markets
Dublin, Jan. 20, 2023 (GLOBE NEWSWIRE) -- The "China Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.China Antirheumatic Drugs...
Brazilian Anti-Rheumatic Drug Market
Brazil Anti-Rheumatic Drug Market Forecasts Report 2022: A $2.83 Billion Market by 2027 - Aging Populations Driving Demand
17. Januar 2023 07:38 ET | Research and Markets
Dublin, Jan. 17, 2023 (GLOBE NEWSWIRE) -- The "Brazil Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.The Brazilian...
22157.jpg
Global Hydroxychloroquine Global Market Outlook 2021 to 2030: Key Players Include Bayer, Novartis, Mylan and Sanofi
30. Dezember 2021 06:08 ET | Research and Markets
Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Hydroxychloroquine Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering....
22157.jpg
Global Rheumatoid Arthritis (RA) Market Analysis & Drug Forecasts, 2019-2029 - Late-Stage RA Pipeline Holds Promise But Likely Won't Match the Utility of JAK Inhibitors
12. Januar 2021 04:08 ET | Research and Markets
Dublin, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering. Global revenues...
22157.jpg
Global Psoriatic Arthritis Drug Forecast and Market Analysis to 2028: Oral Therapeutics Dominate the Late-Stage PsA Pipeline
09. November 2020 07:48 ET | Research and Markets
Dublin, Nov. 09, 2020 (GLOBE NEWSWIRE) -- The "Psoriatic Arthritis: Global Drug Forecast and Market Analysis to 2028" report has been added to ResearchAndMarkets.com's offering. Current therapies...